Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.46 |
| ▸ | GABRD | O14764 | 2/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.46 |
| ▸ | GABRE | P78334 | 2/20 | 0.46 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.46 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.46 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.46 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29956544 | 0.90 | GABRP (0.50) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL11218751 | 0.84 | GABRP (0.48) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4847645 | 0.77 | TP53 (0.30) | TP53 | |
| SCHEMBL11574314 | 0.70 | TGFBR1 (0.33) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL26617402 | 0.69 | — | — | |
| SCHEMBL7536760 | 0.69 | — | — | |
| SCHEMBL1789373 | 0.69 | GABRP (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL7138872 | 0.69 | GABRP (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2413101 | 0.69 | GABRP (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL10499395 | 0.69 | GABRP (0.50) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3924166-B1 | COREACTIVE THREE-DIMENSIONAL PRINTING OF PARTS | PPG IND OHIO INC (US) | 2024-04-24 | — | — | EP | disclosed |
| EP-4349601-A2 | COREACTIVE THREE-DIMENSIONAL PRINTING OF PARTS | PPG Industries Ohio, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117183327-A | Co-reactive three-dimensional printing of parts | PPG工业俄亥俄公司 | 2023-12-08 | — | — | CN | disclosed |
| US-20220126516-A1 | COREACTIVE THREE-DIMENSIONAL PRINTING OF PARTS | PPG INDUSTRIES OHIO, INC. (US) | 2022-04-28 | — | — | US | disclosed |
| CN-113661046-A | Co-reactive three-dimensional printing of parts | PPG工业俄亥俄公司 | 2021-11-16 | — | — | CN | disclosed |
| EP-3257890-B1 | CROSSLINKABLE COMPOSITION | ALLNEX NETHERLANDS BV (NL) | 2021-06-02 | — | — | EP | disclosed |
| EP-3257890-A1 | CROSSLINKABLE COMPOSITION | Allnex Netherlands B.V. (NL) | 2017-12-20 | — | — | EP | disclosed |
| EP-2985308-B1 | CROSSLINKABLE COMPOSITION | ALLNEX NETHERLANDS BV (NL) | 2017-07-19 | — | — | EP | disclosed |
| US-9534081-B2 | Crosslinkable composition crosslinkable with a latent base catalyst | NUPLEX RESINS B.V. (NL) | 2017-01-03 | — | — | US | disclosed |
| EP-2556106-B1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS BV (NL) | 2016-08-10 | — | — | EP | disclosed |
| US-20130210986-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-08-15 | — | — | US | disclosed |
| WO-2013113642-A1 | REPAIR PROCESS AND PRIMER COMPOSITION | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2013-08-08 | — | — | WO | disclosed |
| US-20130053505-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-02-28 | — | — | US | disclosed |
| US-20130041091-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-02-14 | — | — | US | disclosed |
| EP-2556106-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556107-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556108-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011124663-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011124665-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011124664-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041091-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | ARL1, ASH2L, COL1A1 | GABRP 4007/4885GABRD 4691/4885GABRA1 3896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.